January 2, 2026

Happy New Year from Optellum!

As we begin 2026, we’re thinking about beginnings, and for many patients, the journey into lung cancer and lung disease care begins with a single finding on a scan – a small spot on the lung, called a lung nodule.

In this new series to start the year, “Learning Center Highlights”, we delve a little deeper into lung nodules and what they mean for patients.

For many patients, hearing the words “lung nodule” can be unsettling. It raises immediate questions and understandable concern.

The reality is that lung nodules are common and often discovered incidentally during imaging for other reasons. Most nodules are benign, but some require follow-up based on size, growth, and individual risk factors.

What are pulmonary nodules and how are they found?

Pulmonary nodules are small, round, or oval spots in the lung. They are most often found incidentally during CT scans done for other medical reasons. Most nodules are less than 3 cm and cause no symptoms, which is why imaging plays a critical role in early detection.

Most pulmonary nodules are not cancer

95% of pulmonary nodules are benign.1 Common non-cancer causes include prior infections, inflammation, or scar tissue.

When is monitoring or further evaluation recommended?

Clinicians do not treat all nodules the same. Follow-up depends on factors such as nodule size and appearance; growth over time; and patient age and smoking history. Many nodules are safely monitored with scheduled imaging, while others may require additional evaluation to ensure timely care.

How do clinicians assess benign vs malignant nodules?

Clinicians combine imaging features, clinical data, and risk models to estimate the likelihood of cancer. Advanced tools like AI can support this process by helping prioritize nodules that may need closer attention, enabling more confident decisions and earlier intervention when necessary.


Source:
1. https://pubmed.ncbi.nlm.nih.gov/35040882/

Recent posts

May 29, 2026
Cutting-edge AI is great, but how will your health system pay for it?
Optellum is the only Lung Nodule AI with named reimbursement by CMS 5 years and running. Our US health system partners are billing and being reimbursed for using Optellum’s Lung Cancer Prediction (LCP) AI today. We help remove the financial risks often associated with cutting-edge AI adoption. While other tools offer promises, Optellum delivers.
Read more
May 20, 2026
Earlier detection meets the clock: When the 8-week window to surgery can make or break lung cancer survival
In this next topic of our Learning Center Highlight series, we’ll explore why the time between detecting a lung nodule and taking action matters more than ever in lung cancer survival.
Read more
May 18, 2026
Optellum Virtual Nodule Clinic (VNC) vs. RevealDx RevealAI-Lung
Incidental lung nodule care requires more than a one-time risk output. Thoracic programs are multidisciplinary teams comprising pulmonologists, radiologists,...
Read more

Recent posts

Optellum is trusted by industry & academic leaders
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
Certification
Redefining early intervention of lung disease starting with one of the deadliest, lung cancer
Contact us